Clinical Trials Directory

Trials / Conditions / Chalazion

Chalazion

14 registered clinical trials studyying Chalazion — 3 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingEvaluation of Effectiveness and Safety of Intense Pulsed Light Treatment for Chalazion
NCT07405138
Lumenis Be Ltd.N/A
TerminatedEvaluation of Effectiveness and Safety of Intense Pulsed Light Treatment for Chalazion
NCT07039461
Lumenis Be Ltd.N/A
RecruitingEffect of Different Concentrations of Sevoflurane for Anesthesia Induction in Pediatric Ophthalmic Surgery
NCT07450495
Joint Shantou International Eye Center of Shantou University and the Chinese University of Hong KongN/A
UnknownTherapeutic Efficacy of Intense Pulsed Light in the Treatment of Chalazion
NCT05512572
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityN/A
UnknownEfficacy of Intense Pulsed Light in the Treatment of Recurrent Chalazia
NCT05070611
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityN/A
CompletedProbiotics for Chalaziosis Treatment in Children
NCT04322500
University of MoliseN/A
CompletedProbiotics for Treatment of Chalazion in Adults
NCT04342507
University of MoliseN/A
CompletedSafety and Efficacy Study of SUN-131 Transdermal System (TDS) as Compared to Placebo TDS in Patients With a Ch
NCT03248440
Senju USA, Inc.Phase 3
CompletedSafety and Efficacy Study of SUN 131 TDS as Compared to Placebo TDS in Adult Patients With a Chalazion
NCT02338648
Senju USA, Inc.Phase 2
WithdrawnIntralesional Tetracycline Injection in the Treatment of Chalazia
NCT01763437
The Cleveland ClinicEARLY_Phase 1
RecruitingLocal 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
NCT02025023
University of WashingtonPhase 3
CompletedEvaluation of Screening Methods for Treatment of Meibomian Gland Dysfunction
NCT01202747
TearScience, Inc.Phase 2 / Phase 3
CompletedTreatment of Meibomian Gland Dysfunction and Evaporative Dry Eye
NCT00832130
TearScience, Inc.N/A
CompletedPediatric Zylet Safety and Efficacy Study
NCT00420628
Bausch & Lomb IncorporatedPhase 4